Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Jim Cramer in a recent program on CNBC expressed his frustration over the recent market selloff following tariff ...

In the latest trading session, Johnson & Johnson (JNJ) closed at $162.84, marking a +0.02% move from the previous day. This change lagged the S&P 500's 0.64% gain on the day. Elsewhere, the Dow saw an ...

As inflationary pressures persist and the specter of a potential recession looms, investors are understandably seeking ...

The fourth surefire stock to buy right now with the S&P 500 ending March 13 in correction territory is the cheapest " ...

Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

Low bond yields and interest rates are often credited with supporting higher prices in the stock market. That's because lower bond yields can make the potentially higher yields offered by stocks ...

There have been few winning strategies to seek refuge in as the stock rout sparked by President Donald Trump’s start-stop ...

NS Partners Ltd reduced its stake in Johnson & Johnson by 3.7%, selling 3,012 shares in Q4. The institutional investor now ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...